<?xml version="1.0" encoding="UTF-8"?>
<ref id="B182-molecules-26-03005">
 <label>182.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Olivares</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Deshpande</surname>
    <given-names>V.K.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Lahiri</surname>
    <given-names>D.K.</given-names>
   </name>
   <name>
    <surname>Greig</surname>
    <given-names>N.H.</given-names>
   </name>
   <name>
    <surname>Rogers</surname>
    <given-names>J.T.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>X.</given-names>
   </name>
  </person-group>
  <article-title>N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer’s Disease, Vascular Dementia and Parkinson’s Disease</article-title>
  <source>Curr. Alzheimer Res.</source>
  <year>2012</year>
  <volume>9</volume>
  <fpage>746</fpage>
  <lpage>758</lpage>
  <pub-id pub-id-type="doi">10.2174/156720512801322564</pub-id>
  <?supplied-pmid 21875407?>
  <pub-id pub-id-type="pmid">21875407</pub-id>
 </element-citation>
</ref>
